Skip to content

NUTRA PHARMA CORP.: 10-Q filed 2021-08-12

What NUTRA PHARMA CORP. reported in its quarterly report filed 2021-08-12 (fiscal Q3 2020): 37 published measures, 99 facts as tagged in accession 0001493152-21-019469.

This filing

Form
10-Q (quarterly report)
Filed
2021-08-12
Fiscal period
fiscal Q3 2020
Accession
0001493152-21-019469 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All NUTRA PHARMA CORP. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2020-09-30301,592USD
At 2019-12-31339,832USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2020-09-309,946,644USD
At 2019-12-3112,040,867USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2020-09-30-9,645,052USD
At 2020-06-30-10,431,780USD
At 2019-12-31-11,701,035USD
At 2019-09-30-8,126,685USD
At 2019-06-30-7,652,158USD
At 2018-12-31-5,936,593USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2020-07-01 to 2020-09-30587,768USD92
2020-01-01 to 2020-09-301,264,323USD274
2019-07-01 to 2019-09-30-487,072USD92
2019-01-01 to 2019-09-30-2,555,722USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2020-01-01 to 2020-09-30-525,263USD274
2019-01-01 to 2019-09-30-434,938USD273

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2020-07-01 to 2020-09-3013,372USD92
2020-01-01 to 2020-09-3036,728USD274
2019-07-01 to 2019-09-3041,962USD92
2019-01-01 to 2019-09-3093,499USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2020-01-01 to 2020-09-30525,263USD274
2019-01-01 to 2019-09-30434,938USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2020-09-30-66,599,961USD
At 2019-12-31-67,864,284USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2020-07-01 to 2020-09-306,639,683,067shares92
2020-01-01 to 2020-09-306,512,418,374shares274
2019-07-01 to 2019-09-305,057,898,285shares92
2019-01-01 to 2019-09-304,575,964,059shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2020-07-01 to 2020-09-3013,075,446,759shares92
2020-01-01 to 2020-09-3013,006,720,704shares274
2019-07-01 to 2019-09-305,057,898,285shares92
2019-01-01 to 2019-09-304,575,964,059shares273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2020-09-3016,044USD
At 2019-12-316,763USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2020-07-01 to 2020-09-300USD92
2020-01-01 to 2020-09-308,500USD274
2019-07-01 to 2019-09-307,500USD92
2019-01-01 to 2019-09-3064,000USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2020-07-01 to 2020-09-30-186,753USD92
2020-01-01 to 2020-09-30-578,729USD274
2019-07-01 to 2019-09-30-235,182USD92
2019-01-01 to 2019-09-30-811,966USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2020-09-3065,555USD
At 2019-12-3157,806USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2020-09-309,402,842USD
At 2019-12-3110,989,633USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2020-09-30596,868USD
At 2019-12-31583,226USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2020-09-3036,813USD
At 2019-12-3132,479USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2020-07-01 to 2020-09-30197,019USD92
2020-01-01 to 2020-09-30603,387USD274
2019-07-01 to 2019-09-30270,649USD92
2019-01-01 to 2019-09-30879,571USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2020-09-306,127USD
At 2019-12-318,177USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2020-07-01 to 2020-09-3010,266USD92
2020-01-01 to 2020-09-3024,658USD274
2019-07-01 to 2019-09-3035,467USD92
2019-01-01 to 2019-09-3067,605USD273

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2020-07-01 to 2020-09-30256,019USD92
2020-01-01 to 2020-09-30732,887USD274
2019-07-01 to 2019-09-30270,649USD92
2019-01-01 to 2019-09-30879,571USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2020-09-306,745,879,444shares
At 2019-12-315,876,746,111shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2020-09-3050,206,030USD
At 2019-12-3150,283,503USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2020-09-30145,622USD
At 2019-12-31207,530USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2020-09-30162,677USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2020-09-30214,895USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2020-09-30227,843USD
At 2019-12-31216,033USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2020-09-30211,799USD
At 2019-12-31209,270USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2020-09-30723,085USD
At 2019-12-31612,547USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2020-09-3022,615USD
At 2019-12-3117,150USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2020-07-01 to 2020-09-30587,768USD92
2020-01-01 to 2020-09-301,264,323USD274
2019-07-01 to 2019-09-30-487,072USD92
2019-01-01 to 2019-09-30-2,555,722USD273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2020-07-01 to 2020-09-301,105USD92
2020-01-01 to 2020-09-302,529USD274
2019-07-01 to 2019-09-30815USD92
2019-01-01 to 2019-09-303,025USD273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2020-01-01 to 2020-09-305,000USD274

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2020-07-01 to 2020-09-30774,521USD92
2020-01-01 to 2020-09-301,843,052USD274
2019-07-01 to 2019-09-30-251,890USD92
2019-01-01 to 2019-09-30-1,743,756USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2020-01-01 to 2020-09-304,334USD274
2019-01-01 to 2019-09-3027,476USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2020-01-01 to 2020-09-3011,335USD274
2019-01-01 to 2019-09-30927USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2020-01-01 to 2020-09-301,832USD274
2019-01-01 to 2019-09-3075,607USD273

Inspect the source

Entity
NUTRA PHARMA CORP. / CIK 0001119643
Captured
2026-09-20T05:24:45.365Z
SEC response SHA-256
a9ccf17d1b07544de23a6dd72641e83d2b0b8f34b5c47b58fd5a236f1c887339

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001119643.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))